Impact of HLA class I alterations in cancer patients undergoing T cell specific immunotherapy

被引:0
|
作者
Méndez, R [1 ]
Ruiz-Cabello, F [1 ]
Jiménez, P [1 ]
Cabrera, T [1 ]
López-Nevot, MA [1 ]
Knuth, A [1 ]
Jager, E [1 ]
Traversari, C [1 ]
Schadendorff, D [1 ]
Boon, T [1 ]
Garrido, F [1 ]
机构
[1] Hosp Univ, Serv Anal Clin, Granada, Spain
来源
TISSUE ANTIGENS | 2002年 / 59卷
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
引用
收藏
页码:32 / 32
页数:1
相关论文
共 50 条
  • [31] Treatment of bladder cancer with BCG increase alterations in HLA class I expression
    Carretero, Rafael
    Saenz-Lopez, Pablo
    Vazquez, Fernando
    Maleno, Isabel
    Tallada, Miguel
    Cozar, Jose M.
    Garrido, Federico
    Cabrera, Teresa
    TISSUE ANTIGENS, 2009, 73 (05): : 516 - 516
  • [33] HLA class I alterations in head and neck squamous cell carcinoma.
    Murray, AK
    Vora, AR
    Parker, AJ
    Start, R
    Rees, RC
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1997, 25 (02) : S266 - S266
  • [34] Frequency of different HLA class I alterations in melanoma cell lines.
    Méndez, R
    Rodríguez, T
    Ruiz-Cabello, F
    López-Nevot, MA
    Paco, L
    Romero, JM
    Maleno, I
    Pawelec, G
    Garrido, F
    GENES AND IMMUNITY, 2004, 5 : S64 - S64
  • [36] HLA class-I-specific inhibitory receptor in human T lymphocytes: Interference with T-cell functions
    Mingari, MC
    Ponte, M
    Vitale, C
    Schiavetti, F
    Bellomo, R
    Bertone, S
    Nanni, L
    RESEARCH IN IMMUNOLOGY, 1997, 148 (03): : 150 - 155
  • [37] Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations
    Aptsiauri, Natalia
    Carretero, Rafael
    Garcia-Lora, Angel
    Real, Luis M.
    Cabrera, Teresa
    Garrido, Federico
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (11) : 1727 - 1733
  • [38] The Association of Patient HLA Class I Genotype and Genomic Alterations of Non-Small Cell Lung Cancer
    Wang, J.
    Liu, Z.
    Feng, A.
    Tian, K.
    Wei, Y.
    Wang, W.
    Pan, Q.
    Zhang, L.
    Wang, F.
    Zhang, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S542 - S542
  • [39] Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations
    Natalia Aptsiauri
    Rafael Carretero
    Angel Garcia-Lora
    Luis M. Real
    Teresa Cabrera
    Federico Garrido
    Cancer Immunology, Immunotherapy, 2008, 57
  • [40] Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy
    Kopp, Matthias Volkmar
    Hamelmann, Eckard
    Bendiks, Meike
    Zielen, Stefan
    Kamin, Wolfgang
    Bergmann, Karl-Christian
    Klein, Christian
    Wahn, Ulrich
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2013, 24 (05) : 427 - 433